MAPT and Alzheimer disease: A recent study in Alzheimer’s disease (Strom et al., 2022) found that hypometabolism is primarily driven by local atrophy and tau pathology, suggesting that tau-related neuronal dysfunction may explain the dissociation between metabolism and atrophy that is not seen in FTLD TDP-C.